Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Matthew M. Lowe
Don’t wait until something bad happens to make a change
Kari Miller
A lack of integration hampers quality compliance across a product’s life cycle
Etienne Nichols
A well-defined CAPA program is a framework for quality and effectiveness
Grant Ramaley
IAF CertSearch now mandatory for accredited certification bodies
Etienne Nichols
What’s the difference?

More Features

FDA Compliance News
Creates one of the most comprehensive regulatory SaaS platforms for the industry
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community

More News

Quality Digest

FDA Compliance

Transport Pharmaceuticals Appoints New CEO

Published: Tuesday, August 22, 2006 - 22:00

Dennis Goldberg was recently appointed CEO of Transport Pharmaceuticals Inc., a provider of drugs and medical devices for the topical treatment of dermatological conditions.

Goldberg has 20 years of experience in the pharmaceutical and biotechnology industries, and he was most recently president and chief operating officer of Transport. He also founded and served as president and CEO of neXus Therapeutics Inc., the assets and employees of which Transport acquired when it appointed Goldberg CEO.

“Under Dennis’ astute leadership, Transport has evolved into a leading drug/device convergence company with a dedicated management team that possesses core competencies in electrical engineering, chemistry and drug formulation, materials science, and drug development,” says Charles Hadley, Transport’s chairman of the board. “Dennis is the right person to lead Transport into the next phase of its clinical development, and I am delighted to appoint him to this leadership position.”

For more information, visit www.transportpharma.com/news_events/pressrel_2006-08-14.htm


About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.